The FDA announced the first nine companies to be part of its National Priority Voucher program, which includes nine medications.
The program aims to promote novel treatments that will benefit the health interests of Americans, including medications that meet a large, unmet need or reduce downstream health care utilization.
Medications that utilize MFN pricing can also be considered for the program.
As stated, the Priority Voucher program is a new initiative at the agency to promote novel treatments.
The program includes medications that meet a large, unmet need or reduce downstream health care utilization.
Author summary: FDA announces 9 medications in Priority Voucher program.